CAMPANINI, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 1.568
EU - Europa 1.519
AS - Asia 800
SA - Sud America 24
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 3.935
Nazione #
US - Stati Uniti d'America 1.546
IT - Italia 481
CN - Cina 415
IE - Irlanda 300
SG - Singapore 293
SE - Svezia 275
FI - Finlandia 119
DE - Germania 81
TR - Turchia 65
UA - Ucraina 64
FR - Francia 55
GB - Regno Unito 43
AT - Austria 36
BE - Belgio 27
CA - Canada 18
CI - Costa d'Avorio 18
IN - India 15
CZ - Repubblica Ceca 9
RO - Romania 9
BR - Brasile 8
CO - Colombia 8
NL - Olanda 5
CL - Cile 4
EC - Ecuador 4
EU - Europa 4
ES - Italia 3
IR - Iran 3
LT - Lituania 3
MX - Messico 3
HU - Ungheria 2
JP - Giappone 2
PK - Pakistan 2
RU - Federazione Russa 2
AU - Australia 1
BD - Bangladesh 1
BZ - Belize 1
DK - Danimarca 1
HK - Hong Kong 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
PT - Portogallo 1
SC - Seychelles 1
SI - Slovenia 1
TW - Taiwan 1
Totale 3.935
Città #
Chandler 368
Dublin 300
Singapore 212
Ashburn 117
Ann Arbor 116
Parma 108
Boardman 87
Beijing 86
Shanghai 75
Dearborn 71
Jacksonville 66
Izmir 61
New York 55
Nanjing 51
Princeton 48
Vienna 38
Wilmington 34
Rio Saliceto 28
Bologna 26
Brussels 26
San Mateo 22
Helsinki 21
Jinan 20
Woodbridge 19
Abidjan 18
Hefei 18
Los Angeles 18
Bremen 17
Nanchang 17
Chicago 16
Shenyang 16
Hebei 15
Marseille 15
Milan 15
Toronto 14
Modena 13
Changsha 12
Guangzhou 12
Kunming 12
Rome 12
Des Moines 11
Reggio Emilia 9
Sissa 9
Bogotá 8
Leeds 8
Tianjin 8
Fairfield 7
Houston 7
Pune 7
Santa Clara 7
Auburn Hills 6
Dallas 6
Munich 6
Brno 5
Chengdu 5
Crema 5
Seattle 5
Bari 4
Cornaredo 4
Fidenza 4
Jiaxing 4
London 4
Norwalk 4
Pavia 4
Perugia 4
Savignano sul Rubicone 4
Washington 4
Zhengzhou 4
Ancona 3
Falls Church 3
Fremont 3
Haikou 3
Kocaeli 3
Lanzhou 3
Lucknow 3
Madrid 3
Manta 3
Massarosa 3
Montreal 3
Nürnberg 3
Redwood City 3
Springfield 3
Amsterdam 2
Arcevia 2
Assago 2
Belo Horizonte 2
Budapest 2
Capriate San Gervasio 2
Casalecchio di Reno 2
Castelnuovo Rangone 2
Cento 2
Chongqing 2
Clifton 2
Deiva Marina 2
Düsseldorf 2
Erlangen 2
Faisalabad 2
Focsani 2
Forlì 2
Fuzhou 2
Totale 2.536
Nome #
LINFOCITI INFILTRANTI IL TUMORE, BAP-1, VEGFR-2 E IGF-1R NEL MESOTELIOMA PLEURICO MALIGNO 200
Lymphocyte Sub-population in Rectal Biopsies of Horses with Recurrent Colics and Malabsorption (Unhappy Hindgut Syndrome): A Preliminary Study on Morphology and Immune Microenvironment After Recovery 125
Immunohistochemical Detection of Hematopoietic Cell-specific Protein-Tyrosine Phosphatase (Tyrosine Phosphatase SHP-1) in a Series of Endometrioid and Serous Endometrial Carcinoma 122
Neuroendocrine Small Cell Carcinoma of the Cervix: A case report 109
PREDICTIVE AND PROGNOSTIC VALUE OF CLINICAL AND MOLECULAR FEATURES IN PATIENTS UNDERGOING PULMONARY METASTASECTOMY FROM RENAL CELL CARCINOMA 104
Immunohistochemical expression of Napsin A in normal human foetal lungs and congenital and acquired pathologic conditions 103
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 96
On the human amygdaloid body in normal ageing. The aminoacidergic system 94
Glial transporter EAAT2 and glutamatergic turnover in humna neocortex. An immunohistochemical study 92
Immunohistochemical expression of Napsin A in normal human fetal lungs at different gestational ages and in acquired and congenital pathological pulmonary conditions. 89
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 86
Clinicopathological implications of the epidermal growth factor receptor, Cylooxygenase-2 expression and human papilloma virus status in squamous cell carcinoma of the uterine cervix in the elderly 85
COVID-19 in pregnancy: placental pathological patterns and effect on perinatal outcome in five cases. 85
Expression of the glial glutamate transporter EAAT2 in normal ageing 83
Case Report: Irreversible Watery Diarrhea, Severe Metabolic Acidosis, Hypokalemia and Achloridria Syndrome Related to Vasoactive Intestinal Peptide Secreting Malignant Pheochromocytoma 83
Pulmonary metastasectomy for colorectal cancer: Analysis of prognostic factors affecting survival 83
Hypoxia-Inducible Factor (HIF)-1 alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo 82
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy 82
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts 79
C-kit expression in Wilms' tumour: An immunohistochemical study 77
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability 77
GHRELIN PROTECTS AGAINST ETHANOL-INDUCED GASTRIC ULCERS IN RATS: STUDIES ON THE MECHANISMS OF ACTION 76
Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma 73
Immunohistochemical expression of Mesothelin in a series of high grade tubal-ovarian serous carcinoma 72
Analysis of COX-2 expression in Wilms' Tumour. 71
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 71
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo 70
Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas 69
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC 68
On the myoepithelium of human salivary glands. An immunocytochemical study 68
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma 68
Ag-NORs, nucleus-nucleolus-associated antigens (Ki67, PCNA, P-105 and p-120): prognostic markers of meningioma recurrence 68
Clinicopathological implications of the epidermal growth factor receptor, Cylooxygenase-2 expression and human papilloma virus status in squamous cell carcinoma of the uterine cervix in the elderly 66
TUMOR-INFILTRATING LYMPHOCYTES, PDL-1, BAP-1, VEGFR-2 AND IGF-1R EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA 64
Drug-induced glutamine depletion hinders the growth of beta- catenin mutated human liver cancer xenografts 63
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 63
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study 62
TUMOUR-INFILTRATING LYMPHOCYTES AND BAP-1, VEGFR-2 AND IGF-1R EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA 59
Gleason grading of prostate carcinoma in neddle biopsies vs. radical prostatectomy specimens 58
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer 58
PROGNOSTIC SIGNIFICANCE OF NM23 GENE PRODUCT EXPRESSION IN PATIENTS WITH COLORECTAL CARCINOMA TREATED WITH RADICAL INTENT 54
The future potential of genome-wide mutational profiles in HRD detection in breast cancer 54
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment 51
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 51
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial 49
Th9 cells and allergic dermatitis 49
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology? 48
Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil. 46
Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma. 45
MYELOMA CELLS FROM THE BONE MARROW TO THE SKIN: HOW? 42
Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation 38
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 34
Impact of preoperative chemoradiotherapy on tumor infiltrating lymphocytes in locally advanced rectal cancer: The SMART-STAR study 34
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity 32
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 30
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatments 24
Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review 23
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 20
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016) 15
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents 15
7P STK11 and Galectin-3 tissue expression entails a prognostic signature in immunotherapy treated NSCLC patients 14
HIF-1α expression by immunohistochemistry and mRNA-210 levels by real time polymerase chain reaction in post-mortem cardiac tissues: A pilot study 13
RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test 12
Totale 4.096
Categoria #
all - tutte 17.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.002


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020323 0 0 0 0 30 66 70 18 38 66 18 17
2020/2021381 8 25 32 34 28 16 52 26 57 44 33 26
2021/2022337 16 6 23 44 15 10 57 31 12 20 18 85
2022/20231.261 91 161 70 104 117 140 15 94 385 26 47 11
2023/2024609 33 56 55 37 44 134 45 33 27 34 35 76
2024/2025499 66 82 126 121 104 0 0 0 0 0 0 0
Totale 4.096